Search - tctmd.com

Displaying 441 - 460 of 521

Sort: Relevancy | Date

Presentation TCT 2014

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Presenter: Ming Kai Lam

September 16, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

Presentation ESC 2014

SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents

Presenter: Christoph Varenhorst

August 30, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

Presentation CTO 2014

Left Main Restenosis: Incidence, Implications, and Management

Presenter: Roxana Mehran

March 01, 2014

Presentation CTO 2014

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Presenter: Martin B. Leon

March 01, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Presentation CTO 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presenter: Philippe Généreux

March 01, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

‘Simple’ Approach to Repeat PCI Safe, Successful at 4 Years in Unprotected LM Disease

Leah Lawrence

January 22, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

News Conference News ESC 2013

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Yael L. Maxwell

September 02, 2013

Advertisement

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Left Main Restenosis: Incidence, Implications, and Management

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

‘Simple’ Approach to Repeat PCI Safe, Successful at 4 Years in Unprotected LM Disease

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content